Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10573523rdf:typepubmed:Citationlld:pubmed
pubmed-article:10573523lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:10573523lifeskim:mentionsumls-concept:C0083031lld:lifeskim
pubmed-article:10573523lifeskim:mentionsumls-concept:C0160390lld:lifeskim
pubmed-article:10573523lifeskim:mentionsumls-concept:C0392756lld:lifeskim
pubmed-article:10573523lifeskim:mentionsumls-concept:C1517004lld:lifeskim
pubmed-article:10573523pubmed:issue6lld:pubmed
pubmed-article:10573523pubmed:dateCreated1999-12-16lld:pubmed
pubmed-article:10573523pubmed:abstractTextRecombinant human interleukin-11 (rhIL-11) is a multifunctional cytokine that can reduce inflammation through the downregulation of multiple pro-inflammatory mediators from activated macrophages. rhIL-11 also inhibits production of several immunostimulatory cytokines such as IL-12 and interferon gamma (IFN-gamma) and has shown biological activity in multiple animal models of inflammatory disease consistent with immunomodulatory effects on macrophages and T cells. To further elucidate the anti-inflammatory activity of rhIL-11 in vivo, the effect of rhIL-11 in a model of Concanavalin A (Con-A)-induced T-cell-mediated hepatotoxicity was examined. Administration of a single dose of rhIL-11 before Con-A administration reduced centrilobular liver necrosis and enhanced survival. A dose-dependent reduction in serum levels of liver enzymes, tumor necrosis factor alpha (TNF-alpha), and IFN-gamma corresponded with this amelioration of liver damage. No significant change in infiltrating lymphocyte populations in the liver was observed following rhIL-11 treatment. Taken together, these results indicate that rhIL-11 ameliorates T-cell-mediated hepatic injury and suggests its therapeutic potential to treat inflammatory liver disease.lld:pubmed
pubmed-article:10573523pubmed:languageenglld:pubmed
pubmed-article:10573523pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10573523pubmed:citationSubsetIMlld:pubmed
pubmed-article:10573523pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10573523pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10573523pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10573523pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10573523pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10573523pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10573523pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10573523pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10573523pubmed:statusMEDLINElld:pubmed
pubmed-article:10573523pubmed:monthDeclld:pubmed
pubmed-article:10573523pubmed:issn0270-9139lld:pubmed
pubmed-article:10573523pubmed:authorpubmed-author:EricksonJJlld:pubmed
pubmed-article:10573523pubmed:authorpubmed-author:BouchardPPlld:pubmed
pubmed-article:10573523pubmed:authorpubmed-author:DornerA JAJlld:pubmed
pubmed-article:10573523pubmed:authorpubmed-author:DonnellyLLlld:pubmed
pubmed-article:10573523pubmed:authorpubmed-author:TrepicchioW...lld:pubmed
pubmed-article:10573523pubmed:authorpubmed-author:BozziEElld:pubmed
pubmed-article:10573523pubmed:authorpubmed-author:BlissJ LJLlld:pubmed
pubmed-article:10573523pubmed:authorpubmed-author:MaylorRRlld:pubmed
pubmed-article:10573523pubmed:issnTypePrintlld:pubmed
pubmed-article:10573523pubmed:volume30lld:pubmed
pubmed-article:10573523pubmed:ownerNLMlld:pubmed
pubmed-article:10573523pubmed:authorsCompleteYlld:pubmed
pubmed-article:10573523pubmed:pagination1441-7lld:pubmed
pubmed-article:10573523pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:10573523pubmed:meshHeadingpubmed-meshheading:10573523...lld:pubmed
pubmed-article:10573523pubmed:meshHeadingpubmed-meshheading:10573523...lld:pubmed
pubmed-article:10573523pubmed:meshHeadingpubmed-meshheading:10573523...lld:pubmed
pubmed-article:10573523pubmed:meshHeadingpubmed-meshheading:10573523...lld:pubmed
pubmed-article:10573523pubmed:meshHeadingpubmed-meshheading:10573523...lld:pubmed
pubmed-article:10573523pubmed:meshHeadingpubmed-meshheading:10573523...lld:pubmed
pubmed-article:10573523pubmed:meshHeadingpubmed-meshheading:10573523...lld:pubmed
pubmed-article:10573523pubmed:meshHeadingpubmed-meshheading:10573523...lld:pubmed
pubmed-article:10573523pubmed:meshHeadingpubmed-meshheading:10573523...lld:pubmed
pubmed-article:10573523pubmed:meshHeadingpubmed-meshheading:10573523...lld:pubmed
pubmed-article:10573523pubmed:meshHeadingpubmed-meshheading:10573523...lld:pubmed
pubmed-article:10573523pubmed:meshHeadingpubmed-meshheading:10573523...lld:pubmed
pubmed-article:10573523pubmed:meshHeadingpubmed-meshheading:10573523...lld:pubmed
pubmed-article:10573523pubmed:meshHeadingpubmed-meshheading:10573523...lld:pubmed
pubmed-article:10573523pubmed:meshHeadingpubmed-meshheading:10573523...lld:pubmed
pubmed-article:10573523pubmed:meshHeadingpubmed-meshheading:10573523...lld:pubmed
pubmed-article:10573523pubmed:meshHeadingpubmed-meshheading:10573523...lld:pubmed
pubmed-article:10573523pubmed:meshHeadingpubmed-meshheading:10573523...lld:pubmed
pubmed-article:10573523pubmed:meshHeadingpubmed-meshheading:10573523...lld:pubmed
pubmed-article:10573523pubmed:year1999lld:pubmed
pubmed-article:10573523pubmed:articleTitleInterleukin-11 reduces T-cell-dependent experimental liver injury in mice.lld:pubmed
pubmed-article:10573523pubmed:affiliationDepartment of Molecular Medicine, Genetics Institute, Andover, MA 01810, USA.lld:pubmed
pubmed-article:10573523pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10573523lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10573523lld:pubmed